U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976333) titled 'Tumor-Infiltrating Lymphocytes in Endometrial Cancer' on May 09.
Brief Summary: Endometrial cancer (EC) is a leading cancer among women globally. The tumor microenvironment in EC is characterized by complex interactions between cancer cells and immune components. Among these proteins, CD133, WNT-1, and mTOR have emerged as key molecular markers with potential prognostic and therapeutic implications in EC. Understanding the association between these molecular alterations and the immune contexture of EC can provide valuable insights into EC biology and lead to the identification of novel therapeutic targets.
In this study, the spatial...